{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:34:39Z","timestamp":1792892079483,"version":"4.5.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI20C0866"],"award-info":[{"award-number":["HI20C0866"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Woohwangchungsimwon (WCW) is a traditional Korean herbal formula commonly used to treat anxiety and restlessness. However, its potential role in managing behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study evaluated the efficacy and safety of WCW as an adjunctive treatment for BPSD in patients with mild probable AD already receiving donepezil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-four patients receiving donepezil 5\u2005mg daily were randomized 1:1 into an intervention group (WCW add-on, n\u2009=\u200937) or a control group (no additional treatment, n\u2009=\u200937) for 24 weeks. The primary outcome was the change in BPSD measured using the Neuropsychiatric Inventory (NPI). Secondary outcomes were cognitive function and emotional and physical well-being, including depression, anxiety, insomnia, quality of life, and severity of dementia. Safety was assessed via adverse events and laboratory results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-three participants were included. The WCW group demonstrated significantly improved total NPI scores versus controls, particularly in the irritability\/lability subdomain. Analysis of covariance (ANCOVA) confirmed these findings in both the full analysis set (FAS) and per-protocol set (PPS). T-test and rank ANCOVA showed significance in the PPS and a trend in the FAS. The general quality of life dementia scale showed a trend toward improvement. No significant differences in adverse events or laboratory results were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>WCW may be a safe and effective adjunctive therapy for BPSD in patients with mild probable AD. Future studies should adopt more rigorous designs and include patients with broader disease severity to enhance clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The trial was registered with the Clinical Research Information Service (CRIS) on December 10, 2020 (KCT0005669).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877261431692","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:02:02Z","timestamp":1773666122000},"page":"397-409","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer's disease: An assessor-blinded randomized controlled trial"],"prefix":"10.1177","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-7445","authenticated-orcid":false,"given":"Man Gi","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Public Projects, Gyeonggi Provincial Medical Center Suwon Hospital, Suwon, Republic of Korea"},{"name":"Department of Oriental Neuropsychiatry, Graduate School of Dongguk University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8552-2021","authenticated-orcid":false,"given":"Sung-Ho","family":"Woo","sequence":"additional","affiliation":[{"name":"Institute of Interdisciplinary Brain Science, College of Medicine, Dongguk University, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun-Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oriental Neuropsychiatry, Graduate School of Dongguk University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Kyoon","family":"Choi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Ki","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute of Interdisciplinary Brain Science, College of Medicine, Dongguk University, Goyang, Republic of Korea"},{"name":"Dongguk University Ilsan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-3399","authenticated-orcid":false,"given":"Byung Soo","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Oriental Neuropsychiatry, Graduate School of Dongguk University, Seoul, Republic of Korea"},{"name":"Dongguk University Ilsan Oriental Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.53991\/jgn.2022.00045"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13809"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06661-2"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3961\/jpmph.21.478"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-023-09608-0"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00073"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210736"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jama.2023.12548","article-title":"Alzheimer drug Lecanemab gains traditional FDA approval","volume":"330","author":"Harris E","year":"2023","unstructured":"Harris E. Alzheimer drug Lecanemab gains traditional FDA approval. JAMA 2023; 330: 495.","journal-title":"JAMA"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad188"},{"key":"e_1_3_3_12_2","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"6","author":"Birks J","year":"2006","unstructured":"Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2006; 6: CD001190.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-62059-2_428"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113208"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2024.103057"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.713287"},{"key":"e_1_3_3_17_2","first-page":"717","article-title":"The effect of Uhwangchungsimwon on heart rate variability of healthy subjects","volume":"28","author":"Choi CM","year":"2007","unstructured":"Choi CM, Sun JJ, Kim SM, et al. The effect of Uhwangchungsimwon on heart rate variability of healthy subjects. J Int Korean Med 2007; 28: 717\u2013726. (In Korean, English abstract).","journal-title":"J Int Korean Med"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01674"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2017.3925"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2015.1779"},{"key":"e_1_3_3_21_2","first-page":"1","article-title":"A survey on ancient literature records on Woohwangchungsim-won and its potential clinical application","volume":"26","author":"Oh YT","year":"2017","unstructured":"Oh YT, Oh HM, Kim SW, et al. A survey on ancient literature records on Woohwangchungsim-won and its potential clinical application. J Haehwa Med 2017; 26: 1\u201310. (In Korean, English abstract).","journal-title":"J Haehwa Med"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11142036"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1414"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2000.15.6.609"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.02.013"},{"key":"e_1_3_3_26_2","article-title":"Polypharmacy and associated factors in South Korean elderly patients with dementia: an analysis using National Health Insurance claims data","volume":"19","author":"Kim HL","year":"2024","unstructured":"Kim HL, Lee HJ. Polypharmacy and associated factors in South Korean elderly patients with dementia: an analysis using National Health Insurance claims data. PLoS One 2024; 19: e0302300.","journal-title":"PLoS One"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1382990"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/tkm2.1226"},{"key":"e_1_3_3_29_2","unstructured":"NPI Test. FAQ: What constitutes a clinically meaningful change in the NPI total score? Available from: https:\/\/npitest.net\/faqs.html (Accessed August 22 2025)."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2015.05.005"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-012-1031-0"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.33696\/Psychiatry.3.026"},{"key":"e_1_3_3_33_2","first-page":"40","article-title":"Traditional Chinese medicine syndrome types among single-syndrome bipolar mania cases described in Chinese literature","volume":"28","author":"Fengli S","year":"2022","unstructured":"Fengli S, Jianfeng Z, Zhihan G, et al. Traditional Chinese medicine syndrome types among single-syndrome bipolar mania cases described in Chinese literature. Altern Ther Health Med 2022; 28: 40\u201343.","journal-title":"Altern Ther Health Med"},{"key":"e_1_3_3_34_2","first-page":"775","article-title":"The latest research trends on Woohwangchungsim-won: a review in Korean articles","volume":"31","author":"Lee JW","year":"2010","unstructured":"Lee JW, Baek KM, Baek YD, et al. The latest research trends on Woohwangchungsim-won: a review in Korean articles. Korean J Orient Int Med 2010; 31: 775\u2013791. (In Korean, English Abstract).","journal-title":"Korean J Orient Int Med"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182010707"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-142337"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109402"},{"key":"e_1_3_3_38_2","first-page":"2751","article-title":"Glycyrrhiza glabra (Licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology","volume":"10","author":"Wahab S","year":"2021","unstructured":"Wahab S, Annadurai S, Abullais SS, et al. Glycyrrhiza glabra (Licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology. Plants (Basel) 2021; 10: 2751.","journal-title":"Plants (Basel)"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.719197"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.9.1021"},{"key":"e_1_3_3_41_2","first-page":"470","article-title":"The comparative effects of civet-containing and musk-containing WooHwangChungSimWononthecentral nervous system","volume":"44","author":"Choi EW","year":"2000","unstructured":"Choi EW, Kim KN, Shin SD, et al. The comparative effects of civet-containing and musk-containing WooHwangChungSimWononthecentral nervous system. Yakhak Hoeji 2000; 44: 470\u2013477. (In Korean, English Abstract).","journal-title":"Yakhak Hoeji"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261431692","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877261431692","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261431692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:21:01Z","timestamp":1783412461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877261431692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/13872877261431692"],"URL":"https:\/\/doi.org\/10.1177\/13872877261431692","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}